Antag Therapeutics is based on years of collaborative research from the University of Copenhagen with the focus on novel treatments for dietary-related metabolic diseases. The research teams of professor Mette Rosenkilde and professor Jens Juul Holst have discovered a naturally occurring peptide that is being investigated in several human studies.